D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Rio Tinto
RIO
$102B
| $10.8M | 0.01% |
134,263
-555,827
| -81% | -$44.7M |
|
|
BTWN
927
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
| $10.8M | 0.01% |
1,090,625
-1,289,212
| -54% | -$12.7M |
|
|
RAM
928
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
| $10.7M | 0.01% |
1,067,000
| – | – |
|
929
Thor Industries
THO
$5.83B
| $10.7M | 0.01% |
136,354
+114,876
| +535% | +$9.04M |
|
930
JetBlue
JBLU
$1.89B
| $10.7M | 0.01% |
715,562
-560,491
| -44% | -$8.38M |
|
|
HHLA
931
DELISTED
HH&L Acquisition Co.
HHLA
| $10.7M | 0.01% |
1,092,025
-1,306,554
| -54% | -$12.8M |
|
932
Lamb Weston
LW
$7.96B
| $10.6M | 0.01% |
177,689
+61,035
| +52% | +$3.66M |
|
933
BCE
BCE
$22.7B
| $10.6M | 0.01% |
+191,776
| New | +$10.6M |
|
934
Korn Ferry
KFY
$3.93B
| $10.6M | 0.01% |
+163,321
| New | +$10.6M |
|
|
DISCA
935
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $10.6M | 0.01% |
425,058
+223,202
| +111% | +$5.56M |
|
936
Stifel
SF
$11.8B
| $10.6M | 0.01% |
155,734
-122,001
| -44% | -$8.28M |
|
937
Sumitomo Mitsui Financial
SMFG
$107B
| $10.6M | 0.01% |
1,686,259
-22,246
| -1% | -$139K |
|
938
Veritone
VERI
$195M
| $10.6M | 0.01% |
577,710
+37,482
| +7% | +$685K |
|
939
Vishay Intertechnology
VSH
$2.1B
| $10.6M | 0.01% |
538,713
-248,669
| -32% | -$4.87M |
|
|
NLSN
940
DELISTED
Nielsen Holdings plc
NLSN
| $10.6M | 0.01% |
387,492
+246,579
| +175% | +$6.72M |
|
|
AGCB
941
DELISTED
Altimeter Growth Corp. 2
AGCB
| $10.5M | 0.01% |
1,070,460
+239,288
| +29% | +$2.35M |
|
|
PIPP
942
DELISTED
Pine Island Acquisition Corp.
PIPP
| $10.5M | 0.01% |
1,069,417
| – | – |
|
943
Eaton
ETN
$140B
| $10.5M | 0.01% |
69,233
-51,689
| -43% | -$7.84M |
|
|
BMAC
944
DELISTED
Black Mountain Acquisition Corp.
BMAC
| $10.5M | 0.01% |
1,056,348
-34,398
| -3% | -$342K |
|
945
AMC Networks
AMCX
$346M
| $10.5M | 0.01% |
257,456
+111,356
| +76% | +$4.52M |
|
946
Invesco QQQ Trust
QQQ
$371B
| $10.5M | 0.01% |
28,838
-270,380
| -90% | -$98M |
|
|
DISA
947
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
| $10.4M | 0.01% |
1,066,892
| – | – |
|
|
LUXA
948
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
| $10.4M | 0.01% |
1,051,412
+280,213
| +36% | +$2.76M |
|
949
Abacus Life
ABL
$619M
| $10.3M | 0.01% |
1,040,404
+11,500
| +1% | +$114K |
|
|
IGMS
950
DELISTED
IGM Biosciences
IGMS
| $10.3M | 0.01% |
385,712
+253,614
| +192% | +$6.78M |
|